Skip to content
Search

Latest Stories

Social media campaign teaches headwrap trends

A SOCIAL media campaign has been launched with a series of headwrap tutorials to show how modern British women can embrace multiculturalism.

Stoosh, an online platform for young ethnic minority women, launched an Instagram campaign last month featuring a variety of ‘how-to’ guides for wearing headwraps.


Two tutorials are being released every week, featuring a number of models from different backgrounds.

Styles included in the collection of the elegant hair accessory are the bandana style, 1950s style and the top knot turban.

The posts aim to celebrate headwraps from a variety of cultures, including India and Pakistan.

Fatemah Dhanji, one of the models involved in the campaign, said: “I am a woman of culture, I am a woman of religious belief, and I am a woman with both a voice and an identity. It’s important that this is represented in a positive light within the media.

“The headwraps campaign has effectively created a visual portrayal to represent the individuality, beauty and identity of women from all walks of life, which ultimately unites us as one no matter where we come from.

More For You

 Ozempic

Novo Nordisk launches Ozempic in India as diabetes cases climb

Getty Images

Novo Nordisk launches Ozempic in India as type 2 diabetes and obesity cases surge

Highlights:

  • Novo Nordisk is selling Ozempic in India now.
  • Smallest pen, 0.25 mg – about £20.59 (₹2,200) a week (four doses in a pen)
  • Bigger pens – half a mg and 1 mg – cost around £95.18 (₹10,170) and £104.58 (₹11,175)
  • Only specialists can prescribe it – endocrinologists or internal medicine doctors.

Novo Nordisk has started selling Ozempic in India. The smallest weekly pen, 0.25 mg, costs around £20.59 (₹2,200). That covers four doses. Doctors say it lowers blood sugar. Some patients also lose weight. The bigger pens – 0.5 mg and 1 mg – cost about £95.18 (₹10,170) and £104.58 (₹11,175) per month.

 Ozempic Novo Nordisk launches Ozempic in India as diabetes cases climb Getty Images

Keep ReadingShow less